ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 335 filers reported holding ARGENX SE in Q3 2023. The put-call ratio across all filers is 0.33 and the average weighting 0.5%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 39,370 | $14,917,000 | 13.60% |
Tri Locum Partners LP | 82,735 | $31,347,000 | 12.84% |
Avoro Capital Advisors LLC | 1,265,555 | $479,493,000 | 9.48% |
Artal Group S.A. | 400,000 | $151,552,000 | 8.10% |
Finepoint Capital LP | 52,800 | $20,005,000 | 6.92% |
Paradigm Biocapital Advisors LP | 88,816 | $33,651,000 | 6.71% |
Fairmount Funds Management LLC | 73,526 | $27,858,000 | 6.38% |
DCF Advisers, LLC | 25,000 | $9,472,000 | 5.64% |
Redmile Group, LLC | 385,818 | $146,179,000 | 5.58% |
Eagle Health Investments LP | 60,300 | $22,846,000 | 5.33% |